Coapting Cost and Clinical Outcomes in Transcatheter Intervention for Secondary Mitral Regurgitation

Robert O. Bonow, Daniel B. Mark, Patrick T. O'Gara

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations
Original languageEnglish (US)
Pages (from-to)1892-1894
Number of pages3
JournalCirculation
Volume140
Issue number23
DOIs
StatePublished - Dec 3 2019

Funding

Dr Mark reports grants from Eli Lilly & Company, Gilead, AstraZeneca, Bristol Myers Squibb, Merck & Company, and Oxygen Therapeutics and consulting fees from Medtronic and Janssen, outside the submitted work. The other authors report no conflicts.

Keywords

  • Editorials
  • cost effeciveness
  • heart failure
  • mitral valve insufficiency
  • replacement
  • ventricular remodeling

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this